UP-regulation of immune system with .DELTA. 5-Androstenes
US5641766A · kind A · utility
15Cited by
8References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 13, 1995 |
| Grant date | Jun 24, 1997 |
| Priority date | — |
| Expiry date | Sep 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5685
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis by administering a therapeutic amount of a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.